Sabra Health Care REIT (SBRA) grants 8,310 RSUs to director Cusack

Rhea-AI Filing Summary

Cusack Catherine reported acquisition or exercise transactions in this Form 4 filing.

Sabra Health Care REIT director Catherine Cusack received a grant of 8,310 restricted stock units of Common Stock. The grant was made at no cash cost per share and increases her direct holdings to 82,056 shares and stock units in total following the transaction.

The restricted stock units were granted under Sabra’s 2009 Performance Incentive Plan. According to the terms, they vest in equal monthly installments beginning on July 17, 2026 and continuing until the earlier of June 17, 2027 or the day before the next annual stockholders’ meeting.

Footnote disclosure indicates her holdings include 8,310 unvested stock units from this grant and 55,016 stock units that have already vested but for which payment has been deferred. Each stock unit represents the right to receive one share of Sabra’s Common Stock.

Insider Trade Summary

Net Buyer: 8,310 shares

Net Buy 1 txn

Insider Cusack Catherine

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	8,310	$0.00	$0.00

Holdings After Transaction: Common Stock — 82,056 shares (Direct)

Footnotes (2)

1. F1. Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan. The units vest in equal monthly installments beginning July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the date of the next annual stockholders' meeting.
2. F2. Includes 8,310 unvested stock units and 55,016 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.

Key Figures

RSU grant size: 8,310 stock units Grant price: $0.0000 per share Holdings after transaction: 82,056 shares/units +4 more

7 metrics

RSU grant size 8,310 stock units Restricted stock unit award to director on June 17, 2026

Grant price $0.0000 per share No cash cost per share for the RSU grant

Holdings after transaction 82,056 shares/units Total direct Common Stock and stock units following the grant

Unvested units 8,310 stock units Unvested stock units from this grant included in holdings

Vested, deferred units 55,016 stock units Vested stock units with deferred payment right

Vesting start date July 17, 2026 Monthly vesting of RSUs begins

Vesting end date June 17, 2027 Latest possible vesting date, subject to earlier stockholders’ meeting

Key Terms

restricted stock units, 2009 Performance Incentive Plan, vest in equal monthly installments, deferred, +1 more

5 terms

restricted stock units financial

"Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2009 Performance Incentive Plan financial

"Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan."

vest in equal monthly installments financial

"The units vest in equal monthly installments beginning July 17, 2026 and ending on the earlier of June 17, 2027..."

deferred financial

"55,016 stock units that have vested but the payment of which has been deferred."

stock unit financial

"Each stock unit represents the right to receive one share of the Issuer's Common Stock."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/18/2026 - 06:34 PM Accepted by SEC EDGAR 06/18/2026 - 06:33 PM Learn about SEC filing dates

FAQ

What did Sabra Health Care REIT (SBRA) director Catherine Cusack report in this Form 4?

Director Catherine Cusack reported receiving 8,310 restricted stock units of Sabra Health Care REIT Common Stock as a grant. The award was made at no cash cost per share and increases her total direct holdings to 82,056 shares and stock units after the transaction.

How many Sabra Health Care REIT (SBRA) shares and units does Catherine Cusack hold after this grant?

After the grant, Catherine Cusack holds 82,056 Sabra Health Care REIT Common Stock shares and stock units directly. Footnotes state this includes 8,310 unvested stock units from the new grant and 55,016 vested stock units for which payment has been deferred into future settlement.

What are the vesting terms of Catherine Cusack’s 8,310 Sabra (SBRA) restricted stock units?

The 8,310 restricted stock units vest in equal monthly installments starting July 17, 2026. Vesting continues until the earlier of June 17, 2027 or the day before Sabra Health Care REIT’s next annual stockholders’ meeting, tying the award to continued board service over that period.

Under which plan were Catherine Cusack’s Sabra Health Care REIT (SBRA) stock units granted?

The restricted stock units were granted under Sabra Health Care REIT’s 2009 Performance Incentive Plan. This plan provides equity-based compensation, such as stock units, to directors and other participants, aligning their interests with shareholders through awards settled in shares of Common Stock.

Do Catherine Cusack’s Sabra (SBRA) stock units each represent a share of Common Stock?

Yes. Footnote disclosure states each stock unit represents the right to receive one share of Sabra Health Care REIT Common Stock. This applies both to the 8,310 unvested stock units from the new grant and to the 55,016 vested stock units whose payment has been deferred.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cusack Catherine

(Last) (First) (Middle)

C/O SABRA HEALTH CARE REIT, INC.

1781 FLIGHT WAY

(Street)

TUSTIN CALIFORNIA 92782

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sabra Health Care REIT, Inc. [ SBRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/17/2026		A		8,310(1)	A	$0	82,056(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan. The units vest in equal monthly installments beginning July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the date of the next annual stockholders' meeting.

2. Includes 8,310 unvested stock units and 55,016 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	/s/ Michael Costa, as Attorney-in-Fact	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)